Citius Oncology, Inc.

NasdaqCM:CTOR Stock Report

Market Cap: US$126.2m

Citius Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CTOR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders00%
General Public5,254,4347.37%
Public Companies66,049,61592.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 697.5%.


Top Shareholders

Top 1 shareholders own 92.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
92.6%
Citius Pharmaceuticals, Inc.
66,049,615US$116.9m0%no data